Effectiveness of antepartum intravenous iron sucrose: dose timing and impact on outcomes.

Rebecca Feldman HammChristine BlauveltEileen Y WangSindhu K Srinivas

Published in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2019)

Antepartum IVFe effectively increases Hb from the third trimester to delivery admission when administered 2-12 weeks predelivery. There is increasing benefit the further out the IVFe is administered and with an increasing number of doses. Initiatives to combat antepartum anemia should focus on early detection and treatment to best optimize outcomes.

Keyphrases

randomized controlled trial
emergency department
iron deficiency
systematic review
high dose
type diabetes
preterm birth
combination therapy
glycemic control
smoking cessation